Market intelligence, trend analysis and forecasts for the Pharma and Healthcare industries across the regions

Western Europe

The Western Europe Pharma & Healthcare Insight service provides analysis, forecasts and company profiles on a country-by-country basis, covering the key trends impacting pharma and healthcare markets across Western Europe. The service includes access to the very latest analysis plus a searchable archive of articles and data.

To gain FREE trial access for a limited period, click trial.


Latest Stories

Germany / Industry

Multinational drugmaker Bayer is looking to expand its presence in emerging markets and has highlighted the BRIC (Brazil, Russia, India and China), Mexico, South Korea and Turkey as markets in which it will target sales growth. The combined pharmaceutical market of these seven countries reached a value of US$126.05bn in 2009 and by 2014 it is expected to reach US$258.89bn, equating... 2010-03-05


Finland / Industry

Finland's national pharmaceutical industry association, Pharma Industry Finland (PIF), has stated that the reference pricing system, implemented in April 2009, has generated EUR85mn... 2010-03-05


Industry

Anglo-Swedish multinational drugmaker AstraZeneca posted revenues of US$32.8bn for 2009, a 3% increase on US$31.6bn the previous year. The drugmaker also achieved a staggering 23%... 2010-03-04


Industry Developments

Germany

Multinational drugmaker Bayer is looking to expand its presence in emerging markets and has highlighted the BRIC (Brazil, Russia, India and China), Mexico, South Korea and Turkey... 2010-03-05


Finland

Finland's national pharmaceutical industry association, Pharma Industry Finland (PIF), has stated that the reference pricing system, implemented in April 2009, has generated EUR85mn... 2010-03-05


Anglo-Swedish multinational drugmaker AstraZeneca posted revenues of US$32.8bn for 2009, a 3% increase on US$31.6bn the previous year. The drugmaker also achieved a staggering 23%... 2010-03-04


France

Despite a compound annual growth rate (CAGR) of 1.26% in local currency terms and 3.71% in US dollar terms from 2004-2009, BMI's outlook for the French drug market is less optimistic... 2010-03-03

Western Europe InsightWestern Europe Channels Western Europe Countries